Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.32 USD | -2.20% | -7.13% | +70.30% |
03-21 | MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026 | CI |
03-21 | Transcript : MediWound Ltd., Q4 2023 Earnings Call, Mar 21, 2024 |
Sales 2024 * | 24.04M 1.92B | Sales 2025 * | 31.94M 2.55B | Capitalization | 160M 12.8B |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.36B | Net income 2025 * | -18M -1.44B | EV / Sales 2024 * | 6.67 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.02 x |
P/E ratio 2024 * |
-8.97
x | P/E ratio 2025 * |
-9.31
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.27% |
Latest transcript on MediWound Ltd.
1 day | -2.20% | ||
1 week | -7.13% | ||
Current month | -6.93% | ||
1 month | +13.35% | ||
3 months | +45.55% | ||
6 months | +124.94% | ||
Current year | +70.30% |
Managers | Title | Age | Since |
---|---|---|---|
Ofer Gonen
CEO | Chief Executive Officer | 49 | 31/08/03 |
Hani Luxenburg
DFI | Director of Finance/CFO | 52 | 13/05/23 |
Robert Snyder
CTO | Chief Tech/Sci/R&D Officer | 75 | 31/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Wills
BRD | Director/Board Member | 67 | 31/03/17 |
David Fox
BRD | Director/Board Member | 66 | 26/04/20 |
Homi Shamir
CHM | Chairman | 70 | 31/07/22 |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 17.32 | -2.20% | 42,186 |
09/05/24 | 17.71 | -0.23% | 29,023 |
08/05/24 | 17.75 | -6.33% | 70,109 |
07/05/24 | 18.95 | +0.26% | 34,227 |
06/05/24 | 18.9 | +1.34% | 19,101 |
Delayed Quote Nasdaq, May 10, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.30% | 160M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-41.29% | 11.89B | |
-15.50% | 11.91B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- MDWD Stock